ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hepatocellular carcinoma"

  • 2018 American Transplant Congress

    Predictive Value of mRECIST in HCC Response to the Neoadjuvant Locoregional Therapies and Prognosis Affected by the Peak AFP Level before Liver Transplantation

    M. Xu,1 T. Fraum,2 S. Garcia-Aroz,1 N. Vachharajani,1 N. Saad,3 K. Fowler,2 Y. Lin,1 W. Chapman.1

    1Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St. Louis, MO; 2Department of Radiology, Washington University School of Medicine, St. Louis, MO; 3Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY.

    PURPOSE: The modified response evaluation criteria in solid tumors (mRECIST) has been used to assess the response of hepatocellular carcinoma (HCC) to locoregional therapy (LRT)…
  • 2018 American Transplant Congress

    HLA-DR4 Matching and Hepatocellular Carcinoma Recurrence after Liver Transplantation

    M. Xu, S. Garcia-Aroz, N. Vachharajani, Y. Lin, W. Chapman.

    Department of Surgery, Section of Abdominal Transplantation, Washington University School of Medicine, St. Louis, MO.

    PURPOSE: The phenomenon of graft versus host disease after orthotopic liver transplantation (OLT) is estimated at approximately 1-2%, suggesting that under some circumstances, the graft…
  • 2018 American Transplant Congress

    Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry

    H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, F. Filipponi, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.

    Rigshospitalet, Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark; Hôpital Universitaire Paul Brousse, Villejuif, France; National Institute of Public Health, Copenhagen, Denmark; A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy; Hospital Virgen del Rocio, Sevilla, Spain; Hôpital Universitaire Paul Brousse, Villejuif, France; University of Pisa Medical School Hospital, Pisa, Italy; Hôpital Pontchaillou, Rennes, France; Istituto Nazionale Tumori, Milan, Italy; Beaujon Hospital, Clichy, France; Hospital Clínic, Barcelona, Spain; Hospital Universitari de Bellvitge, Barcelona, Spain; S. Orsola Hospital, Bologna, Italy; King's College Hospital, London, United Kingdom; Hôpital Universitaire Paul Brousse, Villejuif, France; Henri Mondor Hospital, Créteil, France; Rigshospitalet, Copnehagen, Denmark.

    PurposeStudies suggest that vascular invasion may be a superior prognostic marker compared with traditional selection criteria, e.g. Milan criteria. We aimed to investigate the prognostic…
  • 2018 American Transplant Congress

    Post-Transplant Outcomes under the New HCC Exception Policy

    T. Ishaque, A. Massie, C. Haugen, D. Segev.

    Surgery, Johns Hopkins Medical Institute, Baltimore, MD.

    In October 2015, OPTN implemented a new policy for liver allocation, under which hepatocellular carcinoma (HCC) patients receive exception points only after a 6-month delay.…
  • 2018 American Transplant Congress

    Locoregional Treatments before Liver Transplantation for Hepatocellular Carcinoma: A Cohort Study from the European Liver Transplant Registry

    H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, P. De Simone, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.

    Rigshospitalet, Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark; Hôpital Universitaire Paul Brousse, Villejuif, France; National Institute of Public Health, Copenhagen, Denmark; Molinette Hospital, Turin, Italy; Hospital Virgen del Rocio, Seville, Spain; Hôpital Universitaire Paul Brousse, Villejuif, France; University of Pisa Medical School Hospital, Pisa, Italy; Hôpital Pontchaillou, Rennes, France; Istituto Nazionale Tumori, Milan, Italy; Beaujon Hospital, Clichy, France; Hospital Clínic, Barcelona, Spain; Hospital Universitari de Bellvitge, Barcelona, Spain; S. Orsola Hospital, Bologna, Italy; King's College Hospital, London, United Kingdom; Hôpital Universitaire Paul Brousse, Villejuif, France; Henri Mondor Hospital, Créteil, France; Rigshospitalet, Copenhagen, Denmark.

    PurposeLocoregional treatment while on the waiting list for liver transplantation (Ltx) for hepatocellular carcinoma (HCC) has shown to improve survival. However, effect of treatment types…
  • 2018 American Transplant Congress

    Financial Burden of Liver Transplant vs Resection for HCC

    J. Butler, N. Skill, C. Kubal, D. O'Brien, J. Kays, J. Fridell, M. Maluccio.

    Surgery, Indiana University, Indianapolis, IN.

    There is considerable commentary regarding liver transplant vs resection for the treatment of hepatocellular carcinoma (HCC). While liver transplant provides longer survival when compared to…
  • 2018 American Transplant Congress

    A Long-Term Experience with Expansion of Milan Criteria for Liver Transplant Recipients

    S. Commander,1 B. Shaw,1 L. Washburn,2 D. Yoeli,2 A. Rana,2 J. Goss.2

    1Duke University, Durham, NC; 2Baylor College of Medicine, Houston, TX.

    Background: The Milan Criteria (MC) have historically determined eligibility for transplantation for hepatocellular carcinoma (HCC). The United Network for Organ Sharing (UNOS) Region 4 expanded…
  • 2018 American Transplant Congress

    Intention to Treat Outcomes of Patients with Hepatocellular Carcinoma Downstaged to within Milan

    P. Tabrizian,1 M. Holzner,1 J. Emond,2 S. Florman,1 R. Brown,2 M. Schwartz,1 K. Halazun.2

    1Transplant, RMTI/Mount Sinai, New York, NY; 2Transplant, New York Presbyterian Hospital, New York, NY.

    Objectives: The success of LRT has served as a tool to select a subgroup of patients exceeding transplant criteria but potentially achieving meaningful outcome with…
  • 2018 American Transplant Congress

    Validation of the alpha-Fetoprotein Model for Hepatocellular Carcinoma Recurrence after Transplantation in an Asian Population

    J. Rhu, J. Kim, G. Choi, C. Kwon, J. Joh, S. Kim.

    Department of Surgery, Samsung Medical Center, Seoul, Republic of Korea.

    Background: This study was designed to validate the alpha-fetoprotein model for predicting recurrence after LT in Korean HCC patients.Methods: Patients who underwent liver transplantation for…
  • 2018 American Transplant Congress

    Cost Analysis of Loco-Regional Bridging Therapy for Hepatocellular Carcinoma: A National Study

    M. Nazzal,1 R. Ouseph,1 X. Huiling,1 M. Schnitzler,1 C. Varma,1 H. Randall,1 J. Tuttle-Newhall,2 D. Axelrod,3 K. Lentine.1

    1Abdominal Transplant, Saint Louis University Hospital, Saint Louis, MO; 2Surgery, East Carolina University/Brody School of Medicine, Greenville, NC.

    Liver transplantation (LT) is cost-effective in the primary treatment of Hepatocellular carcinoma (HCC). Loco-regional therapies (LRTs) have increased as both primary therapy for HCC as…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 23
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences